Welcome to Flow Pharma Inc.

Page Loading...


Stephen Farr

Stephen Farr, Ph.D.

Stephen Farr, Ph.D.


Dr. Farr is CEO of San Francisco Bay Area biotech Zogenix (NASDAQ:ZGNX). He previously held positions of increasing responsibility within pharmaceutical sciences and research and development at Aradigm Corporation before joining Zogenix.

From 1986 to 1994,  Dr. Farr was a tenured professor at the Welsh School of Pharmacy, Cardiff University, U.K., concentrating in the areas of physical pharmacy  and biopharmaceutics. He is a fellow of the American Association of Pharmaceutical Scientists and visiting Associate Professor in the Department of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University.

Dr. Farr is a registered pharmacist in the U.K. and obtained his Ph.D. degree in Pharmaceutics from the University of Wales.